Literature DB >> 22959678

A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.

Kun Nie1, Yuhu Zhang, Limin Wang, Jiehao Zhao, Zhiheng Huang, Rong Gan, Shaohua Li, Lijuan Wang.   

Abstract

Cognitive dysfunction is one of the most critical clinical manifestations of Parkinson's disease (PD), and its accurate and efficient diagnosis is crucial for treatment. We evaluated the psychometric properties of the Beijing version of the Montreal Cognitive Assessment (BJ-MoCA) in 123 Chinese patients with idiopathic PD. The internal consistency and convergent validity of the BJ-MoCA were examined and psychometric characteristics of BJ-MoCA scores were analyzed in PD patients with ''normal'' Mini-Mental State Examination (MMSE) scores. More than half (56.9%) of the patients with normal MMSE scores showed cognitive impairment in multiple cognitive domains, including visuospatial and executive functions, naming, attention, language, delayed recall, and orientation. The impaired delayed recall was less likely to occur in newly diagnosed patients, and the orientation ability in patients with early onset was rarely affected. The multivariate regression analysis revealed that the age of symptom onset and disease severity were independent predictors of cognitive impairment. Thus, the current findings demonstrate that the BJ-MoCA is a reliable tool for screening cognitive dysfunction in Chinese patients with idiopathic PD. It is more sensitive than the MMSE for screening early cognitive decline in non-memory dysfunction.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22959678     DOI: 10.1016/j.jocn.2011.11.039

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  16 in total

1.  Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders.

Authors:  Elena Cecilia Rosca; Loai Albarqouni; Mihaela Simu
Journal:  Neuropsychol Rev       Date:  2019-08-22       Impact factor: 7.444

2.  Thalamic metabolic alterations with cognitive dysfunction in idiopathic trigeminal neuralgia: a multivoxel spectroscopy study.

Authors:  Yuan Wang; Dan Li; Faxiu Bao; Shaohui Ma; Chenguang Guo; Chenwang Jin; Ming Zhang
Journal:  Neuroradiology       Date:  2014-05-13       Impact factor: 2.804

3.  Parkinson's disease patients with pain suffer from more severe non-motor symptoms.

Authors:  Cheng-Jie Mao; Ju-Ping Chen; Xiao-Yi Zhang; Yi Chen; Si-Jiao Li; Jie Li; Kang-Ping Xiong; Wei-Dong Hu; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2014-09-06       Impact factor: 3.307

4.  Characteristics of language impairment in Parkinson's disease and its influencing factors.

Authors:  Lin Liu; Xiao-Guang Luo; Chui-Liang Dy; Yan Ren; Yu Feng; Hong-Mei Yu; Hong Shang; Zhi-Yi He
Journal:  Transl Neurodegener       Date:  2015-01-27       Impact factor: 8.014

5.  The Effects of Group-Based versus Individual-Based Tai Chi Training on Nonmotor Symptoms in Patients with Mild to Moderate Parkinson's Disease: A Randomized Controlled Pilot Trial.

Authors:  Jing Hui Yang; Ya Qun Wang; Sai Qing Ye; You Gen Cheng; Yu Chen; Xiao Zhen Feng
Journal:  Parkinsons Dis       Date:  2017-07-24

6.  Does feedback on daily activity level from a Smart watch during inpatient stroke rehabilitation increase physical activity levels? Study protocol for a randomized controlled trial.

Authors:  Yun Dong; Dax Steins; Shanbin Sun; Fei Li; James D Amor; Christopher J James; Zhidao Xia; Helen Dawes; Hooshang Izadi; Yi Cao; Derick T Wade
Journal:  Trials       Date:  2018-03-09       Impact factor: 2.279

7.  Evaluation of a smartwatch-based intervention providing feedback of daily activity within a research-naive stroke ward: a pilot randomised controlled trial.

Authors:  Sophie Lawrie; Yun Dong; Dax Steins; Zhidao Xia; Patrick Esser; Shanbin Sun; Fei Li; James D Amor; Christopher James; Hooshang Izadi; Yi Cao; Derick Wade; Nancy Mayo; Helen Dawes
Journal:  Pilot Feasibility Stud       Date:  2018-10-06

8.  The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.

Authors:  Ru Tian; Yidan Guo; Pengpeng Ye; Chunxia Zhang; Yang Luo
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

9.  Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors.

Authors:  Qiumei Wang; Zhenxin Zhang; Ling Li; Hongbo Wen; Qun Xu
Journal:  Clin Interv Aging       Date:  2014-02-12       Impact factor: 4.458

10.  Effect of Shenmai injection on cognitive function after cardiopulmonary bypass in cardiac surgical patients: a randomized controlled trial.

Authors:  Lei Chen; Liangrong Wang; Qian Zhuo; Qiong Zhang; Feifei Chen; Liling Li; Lina Lin
Journal:  BMC Anesthesiol       Date:  2018-10-11       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.